MDA, 5th Annual Hereditary Cancer Symposium for Health Care Providers, 4/1/2022 8:30:00 AM – 4/2/2022 11:50:00 AM, Symposium targeted to inter-professional healthcare providers in working with Clinical Cancer Genetics.
A $100,000 gift from UH Mānoa alumnus and philanthropist businessman Jay H. Shidler will help the UH Cancer Center increase public awareness of its work.
Norgine has sought approval for eflornithine (DFMO) for the treatment of patients with high-risk neuroblastoma (HRNB).
ENHERTU Showed Statistically Significant & Clinically Meaningful Improvement in PFS in HR Positive, HER2 Low mBC Following ET in DESTINY-Breast06
MDA, Basic Focus-Assessed Transthoracic Echocardiography (FATE) Workshop, 5/11/2024 7:30:00 AM – 5/11/2024 2:30:00 PM, The FATE protocol is one of several focused cardiac ultrasound (FOCUS)…
Global Partners for the Future Over the course of the last three years, the U.S.-Japan Alliance has reached unprecedented heights. We arrived at this historic…
114 未来の医師への贈りもの Present to Future Doctors上野直人University of Hawaii Cancer Center「50:50」(Cancer Doctor, Cancer Researcher, Cancer Survivor)(UHCC)(Self awarene…
Further research may validate identified biomarkers and refine patient selection criteria for pembrolizumab therapy in breast cancer.
Abstract. Purpose: Accumulating toxicities hinder indefinite chemotherapy for many patients with metastatic/recurrent HER2-negative breast cancer. We conducted a phase II trial of pembrolizumab monotherapy following…
MDA, Basic Focus-Assessed Transthoracic Echocardiography (FATE) Workshop, 5/11/2024 7:30:00 AM – 5/11/2024 2:30:00 PM, The FATE protocol is one of several focused cardiac ultrasound (FOCUS)…
UH brought in $58 million in federal biomedical research grants to the state in fiscal year 2023.
